BioM Advanced Diagnostics
French tech company | Builders Republic
About
Developer of blood-based diagnostic tests that help nephrologists and transplant teams detect and monitor organ rejection without biopsy — analysing patient gene expression and clinical parameters into a rejection-risk score, starting with kidney and lung allografts.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2021
- City
- NANTES
- Region
- Pays de la Loire
- Tracked rounds
- 3
- Amount raised
- 4.3 M€ raised since 2020
Funding rounds
- Seed — 2023
- Seed — 2022
- Seed — 2022
Investors
- Atlantique Vendée Innovation
- bpifrance
- Crédit Agricole Atlantique Vendée
- Ouest Valorisation
- Pays de la Loire Participations
- SATT Ouest Valorisation
- Siparex
- Sodero Gestion
Notes
Liquidation judiciaire prononcée par le Tribunal de commerce de Nantes le 18/12/2024. Spin-off CRTI Nantes, diagnostics biomarqueurs immunitaires.